PT77114B - Process for preparing 3a-(substituted-phenyl)-3a,4,7,7a-tetra- -hydro-4,7-methanoisoindolines - Google Patents
Process for preparing 3a-(substituted-phenyl)-3a,4,7,7a-tetra- -hydro-4,7-methanoisoindolinesInfo
- Publication number
- PT77114B PT77114B PT77114A PT7711483A PT77114B PT 77114 B PT77114 B PT 77114B PT 77114 A PT77114 A PT 77114A PT 7711483 A PT7711483 A PT 7711483A PT 77114 B PT77114 B PT 77114B
- Authority
- PT
- Portugal
- Prior art keywords
- methanoisoindolines
- hydro
- tetra
- phenyl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
- C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/72—4,7-Endo-alkylene-iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/72—4,7-Endo-alkylene-iso-indoles
- C07D209/76—4,7-Endo-alkylene-iso-indoles with oxygen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40249482A | 1982-07-28 | 1982-07-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT77114A PT77114A (en) | 1983-08-01 |
| PT77114B true PT77114B (en) | 1986-01-27 |
Family
ID=23592140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT77114A PT77114B (en) | 1982-07-28 | 1983-07-27 | Process for preparing 3a-(substituted-phenyl)-3a,4,7,7a-tetra- -hydro-4,7-methanoisoindolines |
Country Status (14)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2659215C (en) | 2005-07-27 | 2018-07-10 | Dov Pharmaceutical, Inc. | Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders |
| NZ569630A (en) * | 2006-01-06 | 2011-09-30 | Sepracor Inc | Cycloalkylamines as monoamine reuptake inhibitors |
| EP2370405B1 (en) * | 2008-12-16 | 2013-05-01 | Sunovion Pharmaceuticals Inc. | Triple reuptake inhibitors and methods of their use |
| US20140206740A1 (en) | 2011-07-30 | 2014-07-24 | Neurovance, Inc. | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
| WO2020080165A1 (ja) * | 2018-10-17 | 2020-04-23 | 国立大学法人大阪大学 | 化合物、及びその製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2112548B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1970-11-09 | 1976-07-02 | Eisai Co Ltd | |
| US3917642A (en) * | 1971-11-19 | 1975-11-04 | Cities Service Co | Brominated tricyclic imide flame retardants |
-
1983
- 1983-06-24 EP EP83106172A patent/EP0100426A1/en not_active Ceased
- 1983-07-04 IL IL69150A patent/IL69150A0/xx unknown
- 1983-07-25 JP JP58134518A patent/JPS5933261A/ja active Pending
- 1983-07-26 KR KR1019830003462A patent/KR840005424A/ko not_active Withdrawn
- 1983-07-27 PT PT77114A patent/PT77114B/pt unknown
- 1983-07-27 FI FI832716A patent/FI832716A7/fi not_active Application Discontinuation
- 1983-07-27 PL PL24320283A patent/PL243202A1/xx unknown
- 1983-07-27 ES ES524479A patent/ES8504125A1/es not_active Expired
- 1983-07-27 AU AU17341/83A patent/AU1734183A/en not_active Abandoned
- 1983-07-27 PH PH29309A patent/PH18828A/en unknown
- 1983-07-27 ZA ZA835505A patent/ZA835505B/xx unknown
- 1983-07-27 NO NO832734A patent/NO832734L/no unknown
- 1983-07-27 DK DK344083A patent/DK344083A/da not_active Application Discontinuation
- 1983-07-28 GR GR72073A patent/GR77560B/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI832716A0 (fi) | 1983-07-27 |
| PH18828A (en) | 1985-10-07 |
| KR840005424A (ko) | 1984-11-12 |
| JPS5933261A (ja) | 1984-02-23 |
| PL243202A1 (en) | 1985-07-02 |
| NO832734L (no) | 1984-01-30 |
| PT77114A (en) | 1983-08-01 |
| EP0100426A1 (en) | 1984-02-15 |
| AU1734183A (en) | 1984-02-02 |
| FI832716L (fi) | 1984-01-29 |
| DK344083A (da) | 1984-01-29 |
| IL69150A0 (en) | 1983-11-30 |
| ES524479A0 (es) | 1985-04-01 |
| FI832716A7 (fi) | 1984-01-29 |
| ZA835505B (en) | 1984-04-25 |
| DK344083D0 (da) | 1983-07-27 |
| GR77560B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-09-24 |
| ES8504125A1 (es) | 1985-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RO87533B (ro) | Procedeu pentru prepararea unor n-(biciclicheterociclil)-4-piperidinamine | |
| RO86234B (ro) | Procedeu pentru prepararea unor derivati de aciloxipurine substituite | |
| PT77583A (en) | Improved process for preparing 3-aryl-5-pyrazole derivatives or relating thereto | |
| YU41082A (en) | Process for preparing substituted n-(4-indolylpiperidinoalkyl)-benzimidazolones | |
| PL243555A1 (en) | Process for preparing n-formyl- and n-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides | |
| DE3380061D1 (en) | Process for preparing dinitrobenzophenones | |
| PT77831B (en) | Process for preparing fluoromethylthiooxacephalosporins | |
| DE3380846D1 (en) | Process for preparing 2-alkylamino- and 2-amino-5-alkylpyridines | |
| PT77114B (en) | Process for preparing 3a-(substituted-phenyl)-3a,4,7,7a-tetra- -hydro-4,7-methanoisoindolines | |
| GB2115809B (en) | Process for preparing 4-amino-5-dialkoxy-methylpyrimidine derivatives | |
| YU55383A (en) | Process for obtaining 1,2,4-triazole-1-yl-propionitrile | |
| PT76447B (en) | Process for preparing n-substituted-tetrahydrothiazines | |
| IL70218A0 (en) | Process for preparing oxazolinoazetidinones | |
| PL241785A1 (en) | Process for preparing pyrido-/1,4/-benzodiazepins | |
| DE3366914D1 (en) | Process for preparing 2-hydroxy-2-phenylethylamines | |
| CS455083A2 (en) | Process for preparing 1-aryl-2-amino-1-ethanoles | |
| ZA833123B (en) | Process for preparing cyanohydrincarboxylates | |
| PL235434A1 (en) | Process for preparing novel 1,1-dioxo-3-mercapto-1,4,2-benzodithiazines | |
| PL244814A1 (en) | Process for preparing 4/5/-acetyl-2-methylimidazole | |
| IL70420A (en) | Process for preparing 3-bromo-3-methylcepham derivatives | |
| PT76406A (en) | Process for preparing 2-pyridylalkylamines | |
| YU276482A (en) | Process for preparing 7,16-dioxa-2-aza-10-0-cladinosly-12-0-desosaminyl-4,5-dihdroxy-6-ethyl-3,5,9,11-hexadeca-1-(2)-8-one | |
| RO84760B1 (ro) | Procedeu de preparare a 2, 4-diamino-6-hidroximetilpteridinei | |
| PL242604A2 (en) | Process for preparing ethyl 5,5-dimethyl-2-cyclohexen-1-ylacetate | |
| PL128575B2 (en) | Process for preparing 2-/2,2-dimethylnorbornan-3-yl/-ethylenecyclohexan-1-ol |